| Trial ID: | L1409 |
| Source ID: | NCT00227409
|
| Associated Drug: |
Calcium Disodium Edta (Edetate Calcium Disodium)
|
| Title: |
Long-Term Lead Chelation Therapy and Progressive Renal Insufficiency
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Urologic Disease
|
| Interventions: |
DRUG: calcium disodium EDTA (edetate calcium disodium)
|
| Outcome Measures: |
Primary: The primary end point was an increase in serum creatinine to 2 times the base-line value or the need for dialysis. |
|
| Sponsor/Collaborators: |
Sponsor: Chang Gung Memorial Hospital
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
|
| Enrollment: |
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE|Primary Purpose: TREATMENT
|
| Start Date: |
2001-11
|
| Completion Date: |
2005-10
|
| Results First Posted: |
|
| Last Update Posted: |
2006-10-18
|
| Locations: |
Chang Gung Memorial Hospital, Taipei, Taiwan, 105, China
|
| URL: |
https://clinicaltrials.gov/show/NCT00227409
|
